Literature DB >> 6663409

Pulmonary resection for complications of cystic fibrosis.

L Marmon, D Schidlow, J Palmer, R K Balsara, J M Dunn.   

Abstract

Pulmonary sequelae account for a large proportion of the morbidity and mortality of cystic fibrosis. Bronchiectasis, hemoptysis, and abscess formation are often not responsive to conservative medical therapy. Pulmonary resection in selected cystic fibrosis patients is safe and therapeutically rewarding. Eleven pulmonary resections in ten patients with cystic fibrosis were performed. Patients ranged from 2.5 to 19 years of age. Indications for resection were: (1) abscess and bronchiectasis (nine patients), (2) atelectasis and mass (one patient), and (3) life-threatening hemorrhage (one patient). Surgical resection was employed only for medically refractory lesions which were life-threatening or contaminated otherwise functional lungs. Resection was limited to the most severely diseased areas, sparing functional lung parenchyma when possible. In this series, 9 lobectomies, 1 pneumonectomy, and 1 segmentectomy were performed. Preoperative management included aggressive chest physiotherapy and postural drainage, rigid bronchoscopic lavage, and broad-spectrum parenteral antibiotics. All patients were extubated in the operating room immediately postoperatively. Tracheostomy was not employed. There were no perioperative complications. All patients experienced subjective improvement. Objectively, improvement following surgical resection included: decreased cough and sputum production, and decreased incidence of exacerbations of pulmonary infections. Limited pulmonary resection when combined with intensive preoperative pulmonary toilet is a safe adjunct in the treatment of bronchiectasis and hemoptysis secondary to cystic fibrosis. Pulmonary resection should be limited to only severely destroyed lung parenchyma which is refractory to medical management. In contradistinction to other authors we have not found tracheostomy a necessary adjunct in surgical management.

Entities:  

Mesh:

Year:  1983        PMID: 6663409     DOI: 10.1016/s0022-3468(83)80028-1

Source DB:  PubMed          Journal:  J Pediatr Surg        ISSN: 0022-3468            Impact factor:   2.545


  6 in total

Review 1.  Progressive unilateral lung collapse in cystic fibrosis--a therapeutic challenge.

Authors:  William G Flight; Janet Hildage; A Kevin Webb
Journal:  J R Soc Med       Date:  2012-06       Impact factor: 5.344

2.  Lung resection in cystic fibrosis patients with localised pulmonary disease.

Authors:  J Lucas; G J Connett; R Lea; C J Rolles; J O Warner
Journal:  Arch Dis Child       Date:  1996-05       Impact factor: 3.791

3.  Lobectomy in patients with cystic fibrosis.

Authors:  Shahid I Sheikh; Karen S McCoy; Nancy A Ryan-Wenger; Alpa Patel; Stephen Kirkby
Journal:  Can Respir J       Date:  2014-02-12       Impact factor: 2.409

Review 4.  Nontuberculous mycobacteria: the changing epidemiology and treatment challenges in cystic fibrosis.

Authors:  Janice M Leung; Kenneth N Olivier
Journal:  Curr Opin Pulm Med       Date:  2013-11       Impact factor: 3.155

Review 5.  Infection prevention and chronic disease management in cystic fibrosis and noncystic fibrosis bronchiectasis.

Authors:  Sherstin T Lommatzsch
Journal:  Ther Adv Respir Dis       Date:  2020 Jan-Dec       Impact factor: 4.031

6.  Staphylococcal lung abscess in a child with cystic fibrosis: Case report & review of literature.

Authors:  P Edwards; M Brener; A Isles; N Kapur
Journal:  Respir Med Case Rep       Date:  2020-02-11
  6 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.